GENE ONLINE|News &
Opinion
Blog

2025-09-23|

Ledger Run Appoints Patrick Mizer, Dennis Morgan, and Jody Quint to Leadership Team

by Mark Chiang
Share To

Ledger Run has announced the addition of three seasoned executives to its leadership team as part of efforts to support its growth strategy and accommodate an expanding customer base. The company, which specializes in developing a clinical trial financial operations platform, named Patrick Mizer as Chief Technology Officer (CTO), Dennis Morgan as Chief Financial Officer (CFO), and Jody Quint as Chief Commercial Officer (CCO). This announcement comes six months after John Chinnici assumed the role of CEO.

The newly appointed executives bring extensive experience in their respective fields. Mizer will oversee technological advancements for Ledger Run’s platform, while Morgan will manage financial strategies aimed at scaling operations. Quint is tasked with driving commercial initiatives to enhance customer engagement and market reach. The appointments reflect Ledger Run’s commitment to strengthening its leadership team amid increasing demand for its services in the clinical trial sector.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: September 23, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
Generative AI Enhances Shanshui Animations with Perlin Noise and Diffusion Models
2026-01-16
LATEST
Generative AI Enhances Shanshui Animations with Perlin Noise and Diffusion Models
2026-01-16
QMSR Town Hall Discusses Integrating Risk Management into Product Design and Fostering Quality Culture in Pharma and Medical Devices
2026-01-16
Magnesium Oxychloride Cement from Dolomite Ore Developed with Self-Cleaning Properties
2026-01-16
New Database MitoCommun Developed to Map Mitochondrial Communication Networks
2026-01-16
New Model Combines Computational Methods and Pharmacological Knowledge to Predict Adverse Drug Interactions
2026-01-16
Tolerance Bio Targets Congenital Athymia with Therapies to Restore Thymus Function
2026-01-16
United States to Implement International Pricing Benchmarks for Drug Costs by 2026
2026-01-16
EVENT
2026-02-09
World Health Expo Dubai
Dubai Exhibition Centre, Dubai
2026-02-17
BIO Asia 2026 (Life Science Partnerships)
Hyderabad, India
2026-02-24
Rare Disease Week on Capitol Hill (Policy and Advocacy)
Capitol Hill, Washington, D.C.
2026-03-09
HIMSS26 (Digital Health & Hospital IT)
Las Vegas, Nevada
2026-03-23
BIO Europe Spring (Biotech Partnering)
Lisbon, Portugal
Scroll to Top